CC
CQS Cayman’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $4.41M | Sell |
65,474
-3,000
| -4% | -$202K | 0.19% | 79 |
|
|
2019
Q2 | $5.86M | Buy |
68,474
+26,780
| +64% | +$2.29M | 0.23% | 61 |
|
|
2019
Q1 | $3.7M | Sell |
41,694
-27,400
| -40% | -$2.43M | 0.17% | 70 |
|
|
2018
Q4 | $5.88M | Buy |
69,094
+10,394
| +18% | +$885K | 0.41% | 49 |
|
|
2018
Q3 | $5.69M | Sell |
58,700
-117,800
| -67% | -$11.4M | 0.27% | 56 |
|
|
2018
Q2 | $16.6M | Buy |
176,500
+45,000
| +34% | +$4.24M | 0.89% | 35 |
|
|
2018
Q1 | $10.7M | Buy |
131,500
+5,000
| +4% | +$405K | 0.49% | 52 |
|
|
2017
Q4 | $11.3M | Buy |
126,500
+11,000
| +10% | +$981K | 0.71% | 45 |
|
|
2017
Q3 | $10.8M | Buy |
115,500
+111,900
| +3,108% | +$10.4M | 0.72% | 48 |
|
|
2017
Q2 | $327K | Sell |
3,600
-400
| -10% | -$36.3K | 0.02% | 106 |
|
|
2017
Q1 | $351K | Buy |
+4,000
| New | +$351K | 0.03% | 107 |
|
|
2016
Q4 | – | Sell |
-3,750
| Closed | -$347K | – | 117 |
|
|
2016
Q3 | $347K | Sell |
3,750
-46,378
| -93% | -$4.29M | 0.03% | 126 |
|
|
2016
Q2 | $3.9M | Sell |
50,128
-12,792
| -20% | -$995K | 0.34% | 63 |
|
|
2016
Q1 | $5.19M | Buy |
62,920
+22,320
| +55% | +$1.84M | 0.52% | 47 |
|
|
2015
Q4 | $4.25M | Buy |
40,600
+11,100
| +38% | +$1.16M | 0.29% | 58 |
|
|
2015
Q3 | $3.11M | Sell |
29,500
-10,500
| -26% | -$1.11M | 0.26% | 58 |
|
|
2015
Q2 | $5.47M | Sell |
40,000
-83,000
| -67% | -$11.4M | 0.33% | 54 |
|
|
2015
Q1 | $15.3M | Buy |
123,000
+48,000
| +64% | +$5.98M | 0.72% | 20 |
|
|
2014
Q4 | $6.78M | Sell |
75,000
-10,000
| -12% | -$904K | 0.45% | 45 |
|
|
2014
Q3 | $6.13M | Buy |
+85,000
| New | +$6.13M | 0.36% | 50 |
|